We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.09B
AUM Growth
+$1.38B
Cap. Flow
+$926M
Cap. Flow %
18.19%
Top 10 Hldgs %
35.13%
Holding
112
New
25
Increased
38
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$137M
2
AGN.PRA
Allergan plc
AGN.PRA
+$89.2M
3
CNC icon
Centene
CNC
+$76.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.1M
5
JD icon
JD.com
JD
+$52M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$243M
2
UHS icon
Universal Health Services
UHS
+$91.1M
3
PCRX icon
Pacira BioSciences
PCRX
+$87.8M
4
MCK icon
McKesson
MCK
+$72.1M
5
BABA icon
Alibaba
BABA
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.12%
2 Technology 12.48%
3 Communication Services 5.27%
4 Consumer Discretionary 4.56%
5 Financials 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTES icon
51
NetEase
NTES
$76.5B
$34.3M 0.67%
649,935
+151,555
+30% +$8.7M
MOH icon
52
CALL
Molina Healthcare
MOH
$10.3B
$33.7M 0.66%
+490,300
New +$31.9M
ICLR icon
53
Icon
ICLR
$12.8B
$32.3M 0.63%
283,195
+63,005
+29% +$6.7M
MMSI icon
54
Merit Medical Systems
MMSI
$4.43B
$30M 0.59%
707,440
+322,539
+84% +$13M
ELGX
55
DELISTED
Endologix Inc
ELGX
$29.7M 0.58%
665,898
+105,951
+19% +$4.83M
ZEN
56
DELISTED
ZENDESK INC
ZEN
$28.6M 0.56%
981,832
+431,300
+78% +$12.1M
ESPR
57
DELISTED
Esperion Therapeutics
ESPR
$27.5M 0.54%
548,682
+334,702
+156% +$16.1M
JNCE
58
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$26.9M 0.53%
1,727,997
+1,029,838
+148% +$14.6M
IWM icon
59
iShares Russell 2000 ETF
IWM
$80.9B
$24M 0.47%
+161,700
New +$22.8M
XENT
60
DELISTED
Intersect ENT, Inc
XENT
$23.9M 0.47%
768,366
+374,028
+95% +$11.1M
INGN icon
61
Inogen
INGN
$167M
$22.9M 0.45%
+241,057
New +$23.2M
HRC
62
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$22.6M 0.44%
304,738
+157,434
+107% +$12.1M
NVDA icon
63
NVIDIA
NVDA
$5.01T
$22.2M 0.44%
4,977,360
+899,400
+22% +$3.74M
TREE icon
64
LendingTree
TREE
$544M
$21.3M 0.42%
86,982
+15,297
+21% +$3.3M
SWKS icon
65
Skyworks Solutions
SWKS
$9.06B
$20.5M 0.4%
+201,435
New +$20.9M
XYZ
66
Block Inc
XYZ
$45.9B
$20.4M 0.4%
708,119
-126,423
-15% -$3.31M
BLK icon
67
Blackrock
BLK
$164B
$20.3M 0.4%
45,330
-612
-1% -$261K
V icon
68
Visa
V
$677B
$20M 0.39%
190,147
-371,543
-66% -$37.7M
CLVS
69
DELISTED
Clovis Oncology, Inc.
CLVS
$18.2M 0.36%
220,487
-149,654
-40% -$11.9M
CUTR
70
DELISTED
Cutera, Inc.
CUTR
$17.7M 0.35%
+427,163
New +$14.1M
ARAY icon
71
Accuray
ARAY
$28.4M
$16.7M 0.33%
4,168,513
-647,821
-13% -$2.78M
VMC icon
72
Vulcan Materials
VMC
$36.3B
$14.2M 0.28%
118,745
– –
CSII
73
DELISTED
Cardiovascular Systems, Inc.
CSII
$12.6M 0.25%
445,891
+104,675
+31% +$3.18M
MDXG icon
74
PUT
MiMedx Group
MDXG
$626M
$11.7M 0.23%
+981,400
New +$14.6M
HAPN
75
Happen Inc
HAPN
$2.08B
$9.94M 0.2%
+326,389
New +$9.39M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2017 Portfolio in Review

As of Q3 2017, PFM Health Sciences held 112 positions worth $5.09B, up 37% from $3.71B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences deployed $926M of net new capital in Q3 2017, opening 25 new positions and adding to 38 existing holdings. Its largest new stake was Allergan plc: 107,410 shares worth $79.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $243M trimmed.

  • PFM Health Sciences's largest Q3 2017 buy was Allergan plc: 107,410 shares worth $79.2M.
  • PFM Health Sciences added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $137M increase.
  • PFM Health Sciences's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $243M.
  • PFM Health Sciences fully exited Universal Health Services in Q3 2017, selling an estimated $91.1M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $5.09B portfolio in Q3 2017.
  • PFM Health Sciences opened 25 new positions and closed 24 in Q3 2017.
  • PFM Health Sciences's portfolio value rose 37% quarter-over-quarter to $5.09B.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.